Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - GalaGen Inc. (OTC BB:GGEN.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Insider | Financials
Recent Events
Aug 14Earnings Announcement
Aug  8Price hit new 52-week low ($0.11)
Location
301 Carlson Parkway, Suite 301
Minnetonka, MN 55305
Phone: (952) 258-5500
Fax: (952) 249-8221
Email: info@galagen.com
Employees (last reported count): 17
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 52%
·Institutional: 2% (3% of float)
(5 institutions)
·Net Inst. Selling: 63.0K shares (+45.31%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
GalaGen Inc. is engaged in the development of foods, beverages and dietary supplements that help enhance the immune system and take advantage of all of the benefits offered by colostrum. The Company is focusing its efforts on channels that demand immune-enhancing benefits in certain segments of the consumer food and beverage product markets and in certain segments of the dietary supplement markets. In addition, the Company continues to market its critical care line of products through its licensee partner, Hormel HealthLabs, a subsidiary of Hormel Foods Corporation. The Company's immune-enhancing ingredient is derived from bovine colostrum, the first milk from a dairy cow after its calf is born, and has been branded, Proventra Brand Natural Immune Components. The primary immune-enhancing components of Proventra are antibodies, which are proteins that enhance the body's immune system to protect against harmful pathogens.
More from Market Guide: Expanded Business Description

Financial Summary
GalaGen Inc. is a nutritional products company which is developing a line of immume-enhancing nutritional products and beverages using its proprietary dairy ingredient technology. For the six months ended 6/30/01, revenues fell 60% to $130 thousand. Net loss before acctg. change fell 16% to $1.8 million. Revenues primarily reflect lower product development income. Lower loss reflects reduced marketing, product development and amortization expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Robert Hoerr, M.D., Ph.D., 51
Chairman, CTO
$370K
Henry Cardello, 49
Pres, CEO, Director
403K
Franklin Kuhar, 44
CFO, VP, Sec.
180K
Michael Cady, 48
VP, Manufacturing and Engineering
159K
Eileen Bostwick, Ph.D., 50
VP of R&D
150K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:GGEN.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 8-Aug-2001
$0.11 
Recent Price$0.20 
52-Week High
on 18-Sep-2000
$1.344
Beta0.97 
Daily Volume (3-month avg)18.8K
Daily Volume (10-day avg)21.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-82.2%
52-Week Change
relative to S&P500
-76.2%
Share-Related Items
Market Capitalization$2.46M
Shares Outstanding12.3M
Float5.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.08 
Earnings (ttm)-$0.33 
Earnings (mrq)-$0.07 
Sales (ttm)$0.06 
Cash (mrq)$0.00 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)3.39 
Income Statements
Sales (ttm)$697.0K
EBITDA (ttm)-$3.47M
Income available to common (ttm)-$3.84M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-185.51%
Return on Equity (ttm)-636.02%
Financial Strength
Current Ratio (mrq)0.35 
Debt/EquityN/A 
Total Cash (mrq)$15.0K
Short Interest
As of 8-Dec-2000
Shares Short1,000 
Percent of Float0.0%
Shares Short
(Prior Month)
2,000 
Short Ratio0.01 
Daily Volume81.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.